Skip to content
Search

Latest Stories

No decision yet on Covid-19 vaccines for healthy children: Nadhim Zahawi

Vaccines minister Nadhim Zahawi on Sunday (Sep 5) said a decision had not yet been taken on whether healthy 12 to 15-year-old children should be vaccinated against Covid-19, following reports that a rollout could begin in the coming days.

Britain's Joint Committee on Vaccination and Immunisation (JCVI) on Friday (Sep 3) declined to recommend vaccinations for children in that group, taking a precautionary approach due to a rare risk of heart inflammation, but adding the issue was finely balanced.


The government is consulting medical advisers to seek advice on wider considerations, such as the impact on schools, and may still give the go-ahead to broad vaccination of the age group.

Some newspapers reported confidence among ministers that the chief medical officers would swiftly back shots for healthy 12- to 15-year-olds, but Zahawi said the government would not prejudge the decision.

"No decision will be made until we hear back from the chief medical officers," Zahawi told the BBC.

Government officials have emphasised that 12- to 15-year-olds who are vulnerable to Covid-19 are already eligible for vaccination, as well as all people over 16.

The four nations of the United Kingdom, which have recorded 133,000 Covid deaths, control their own health policy, although all have followed JCVI advice on vaccine rollout thus far.

Zahawi confirmed that proof of vaccination would be required in England for some large events from the end of this month once all adults have been offered two shots.

He also said that the government was still finalising plans for a vaccine booster programme following interim advice from the JCVI that one might be needed for the vulnerable and elderly.

"It is very likely that we will begin boosting those groups, as... I hope the interim then becomes final advice, by the middle of this month," he said.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less